Department of Anesthesiology and Critical Care, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Expert Rev Clin Pharmacol. 2020 Feb;13(2):135-146. doi: 10.1080/17512433.2020.1717947. Epub 2020 Jan 28.
: The use of ketamine infusions for chronic pain has surged, with utilization exceeding the proliferation of knowledge. A proposed mechanism for the long-term benefit in chronic pain is that ketamine may alter the affective-motivational component of pain.: In this review, we discuss the classification and various dimensions of pain, and explore the effects of ketamine on different pain categories and components. The relationship between ketamine's action at the NMDA receptor, the development of chronic pain, and the its possible role in preventing the persistence of pain are examined. We also summarize animal models evaluating the antinociceptive effects of ketamine and risk mitigation strategies of ketamine-associated side effects.: Although ketamine exerts most of its analgesic effects via the NMDA receptor, recent evidence suggests that other receptors such as AMPA, and active metabolites such as nor-ketamine, may also play a role in pain relief and alleviation of depression. Data from clinical studies performed in patients with chronic pain and depression, and the observation that ketamine's analgesic benefits outlast its effects on quantitative sensory testing, suggest that the enduring effects on chronic pain may be predominantly due ketamine's ability to modulate the affective-motivational dimension of pain.
:氯胺酮输注在慢性疼痛中的应用激增,其应用的增长速度超过了相关知识的普及速度。氯胺酮在慢性疼痛中具有长期益处的一个提出的机制是,氯胺酮可能会改变疼痛的情感动机成分。:在这篇综述中,我们讨论了疼痛的分类和各个维度,并探讨了氯胺酮对不同疼痛类别和成分的影响。研究了氯胺酮在 NMDA 受体上的作用、慢性疼痛的发展及其在预防疼痛持续存在中的可能作用之间的关系。我们还总结了评估氯胺酮的抗伤害作用的动物模型和减轻氯胺酮相关副作用的风险缓解策略。:尽管氯胺酮主要通过 NMDA 受体发挥其镇痛作用,但最近的证据表明,其他受体,如 AMPA,以及活性代谢物,如去甲氯胺酮,也可能在缓解疼痛和抑郁方面发挥作用。来自慢性疼痛和抑郁症患者的临床研究数据,以及氯胺酮的镇痛效果持续时间超过其对定量感觉测试的影响的观察结果表明,氯胺酮对慢性疼痛的持久影响可能主要是由于其调节疼痛的情感动机维度的能力。